Remote ILD Monitoring With Real-Time Provider Alerts

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Interstitial lung disease (ILD) is often misdiagnosed or diagnosed through exclusion, leading to delayed treatment initiation, increased resource utilization, and higher morbidity, particularly in non-small cell lung cancer (NSCLC) patients, due to the risk of pneumonitis, which is exacerbated by limited awareness and inability to timely manage the condition.

Innovation Solution

A remote monitoring system that collects patient data, including physiological and subjective data, using a rule-based and longitudinal algorithm to identify risk factors and alert healthcare providers to potential ILD through a cloud-based platform, enabling early detection and management of symptoms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If HCPs use traditional diagnostic methods for ILD, then diagnosis can be made, but it leads to misdiagnosis or delayed diagnosis through exclusion

Engineering Contradiction:

Improvediagnosis accuracyVSAvoiddiagnosis time

Core Design Contradiction:

Measurement precisionVSLoss of time

Solution Approach 1:

The system performs preliminary actions by continuously monitoring patients at risk for ILD using algorithms that analyze symptoms, vital signs, and treatment data before ILD develops. This early detection enables proactive intervention rather than reactive diagnosis, resolving the contradiction between diagnosis accuracy and time delay.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The system implements feedback mechanisms where algorithm outputs are continuously fed back to HCPs through notifications and dashboards. This real-time feedback loop enables continuous monitoring and adjustment, improving both diagnosis accuracy and reducing time loss by keeping HCPs informed of changing patient status.

Inventive Principle:

Principle #23Feedback

2Reliability

If HCPs monitor patients continuously for ILD, then early detection is enabled, but resource utilization increases

Engineering Contradiction:

Improveearly detection capabilityVSAvoidresource utilization

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The system enables self-service monitoring where the algorithm automatically collects, analyzes, and monitors patient data without requiring constant HCP involvement. Patients use wearable devices and mobile apps to provide data, and the system autonomously detects anomalies, reducing the burden on HCPs while maintaining reliable early detection.

Inventive Principle:

Principle #25Self-service

Solution Approach 2:

The patent replaces manual mechanical monitoring processes with automated electronic systems. Algorithms substitute for HCP review of continuous data streams, and electronic notifications replace manual chart reviews. This substitution maintains detection reliability while significantly reducing resource utilization.

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

3Reliability

If HCPs are aware of pneumonitis risk, then timely management is possible, but patient awareness remains limited

Engineering Contradiction:

Improvetimely management capabilityVSAvoidpatient awareness

Core Design Contradiction:

ReliabilityVSLoss of information

Solution Approach 1:

The system provides feedback to patients through mobile app notifications and educational materials, keeping them informed of their ILD risk status and symptoms to report. This patient feedback mechanism bridges the awareness gap while maintaining HCP capability for timely management through the same notification system.

Inventive Principle:

Principle #23Feedback

Solution Approach 2:

The algorithm and notification system serve as intermediaries between patients and HCPs. They translate complex medical information into actionable alerts for patients while simultaneously notifying HCPs of concerning trends, enabling timely management without requiring direct patient-HCP communication for every detail.

Inventive Principle:

Principle #24Intermediary (Mediator)

4Productivity

If treatments with pneumonitis risk are used, then therapeutic benefit increases, but ILD risk increases

Engineering Contradiction:

Improvetherapeutic benefitVSAvoidILD risk

Core Design Contradiction:

ProductivityVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary risk assessment and continuous monitoring during treatment, enabling early detection of ILD before it becomes severe. This allows HCPs to maintain beneficial treatments while intervening early to prevent harmful ILD progression, resolving the contradiction between therapeutic benefit and harm.

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The system implements continuous feedback loops that monitor treatment response and ILD signs in real-time. When ILD symptoms emerge, the system notifies HCPs immediately, enabling dynamic adjustment of treatment to maintain benefits while preventing harm through timely intervention.

Inventive Principle:

Principle #23Feedback

Data Source

PatentUS20250352141A1Methods and systems for monitoring interstitial lung disease patient events in real-time

Publication Date: 2025.11.20 EVINOVA AG

AI summary

A patient at risk of lung disease due to a prescribed treatment may be remotely monitored. A cloud server may receive data collected from a patient and analyze the data to determine if the patient shows signs of onset or worsening interstitial lung disease. The cloud server may transmit the analyzed data to a healthcare provider in real-time or near real-time to provide timely symptom management to the patient.